Part 5/7:
The project estimates that their insulin could be produced at up to 98% lower cost than commercial products. If successful, this could dramatically reduce prices and improve global access, bringing hope to millions who currently face life-threatening choices due to cost barriers.
Regulatory agencies like the FDA are beginning to adapt, easing restrictions around insulin production and oversight, which could accelerate the availability of affordable options. The Open Insulin team envisions community labs across the globe providing local production capabilities, fostering independence and control over life-saving medication.